phase iii trial shows pembrolizumab preferable to ipilimumab in advanced melanoma
Published 9 years ago • 846 plays • Length 5:37Download video MP4
Download video MP3
Similar videos
-
24:18
pembrolizumab is better than ipilimumab for advanced melanoma in phase iii trial
-
19:53
phase ii trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
4:07
phase ii trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
-
3:16
#esmo22 highlights on tils versus ipilimumab in patients with advanced melanoma: the phase 3 study
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
6:35
phase iii study finds initial nivolumab-based treatment halts melanoma progression
-
0:58
combination nivolumab and ipilimumab shows efficacy in advanced melanoma
-
2:48
checkmate067 outcomes: nivolumab plus ipilimumab in advanced melanoma
-
8:28
success for ipilimumab and nivolumab combo in advanced melanoma
-
10:05
nivolumab alone superior to ipilimumab alone in advanced melanoma
-
1:13
checkmate 067: nivolumab plus ipilimumab combination therapy in advanced melanoma
-
0:59
checkmate 067: phase 3 trial of nivolumab in melanoma
-
3:35
keynote-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
-
3:30
dosing regiment in the combination of ipilimumab and nivolumab in stage iii melanoma
-
3:47
phase 3 checkmate 067 trial of nivolumab in untreated advanced melanoma
-
3:31
comment: adjuvant ipilimumab in high-risk melanoma
-
3:06
comment: immunotherapy combo increases median survival in advanced melanoma
-
5:18
neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage iii melanoma